L. Silva Miguel

1.1k total citations
40 papers, 153 citations indexed

About

L. Silva Miguel is a scholar working on Economics and Econometrics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, L. Silva Miguel has authored 40 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 6 papers in Oncology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in L. Silva Miguel's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Economic and Financial Impacts of Cancer (7 papers) and Cardiac Arrhythmias and Treatments (4 papers). L. Silva Miguel is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Economic and Financial Impacts of Cancer (7 papers) and Cardiac Arrhythmias and Treatments (4 papers). L. Silva Miguel collaborates with scholars based in Portugal, United States and United Kingdom. L. Silva Miguel's co-authors include Jorge Ferreira, Evangelista Rocha, P.A. Laires, Ruifeng Xu, Manuel Carrageta, James M. Pellissier, Aki Tsuchiya, Jingshu Wang, Richard Edlin and Paul Dolan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Breast Cancer Research and Treatment and Value in Health.

In The Last Decade

L. Silva Miguel

30 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Silva Miguel Portugal 8 77 24 23 16 16 40 153
Sarvenaz Shahin Iran 9 18 0.2× 42 1.8× 12 0.5× 19 1.2× 17 1.1× 19 197
Katherine M Soltys United States 3 54 0.7× 40 1.7× 5 0.2× 18 1.1× 16 1.0× 3 123
Zoey Chopra United States 8 32 0.4× 37 1.5× 10 0.4× 30 1.9× 58 3.6× 27 203
Julia Caroline Michaeli Germany 9 74 1.0× 27 1.1× 20 0.9× 15 0.9× 30 1.9× 23 249
Mingjun Rui China 8 85 1.1× 118 4.9× 15 0.7× 26 1.6× 96 6.0× 20 268
Staffan Schön Sweden 6 17 0.2× 13 0.5× 24 1.0× 10 0.6× 13 0.8× 10 210
Harkiran Sagoo United Kingdom 7 17 0.2× 19 0.8× 10 0.4× 19 1.2× 6 0.4× 10 172
Shilpa S. Murthy United States 8 31 0.4× 78 3.3× 12 0.5× 11 0.7× 24 1.5× 26 181
Yek‐Ching Kong Malaysia 9 57 0.7× 108 4.5× 10 0.4× 18 1.1× 12 0.8× 33 188
Carole Longson United Kingdom 10 138 1.8× 28 1.2× 55 2.4× 43 2.7× 12 0.8× 22 265

Countries citing papers authored by L. Silva Miguel

Since Specialization
Citations

This map shows the geographic impact of L. Silva Miguel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Silva Miguel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Silva Miguel more than expected).

Fields of papers citing papers by L. Silva Miguel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Silva Miguel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Silva Miguel. The network helps show where L. Silva Miguel may publish in the future.

Co-authorship network of co-authors of L. Silva Miguel

This figure shows the co-authorship network connecting the top 25 collaborators of L. Silva Miguel. A scholar is included among the top collaborators of L. Silva Miguel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Silva Miguel. L. Silva Miguel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silva, Joana, Gabriela Sousa, Luís Teixeira da Costa, et al.. (2025). Burden of Disease and Cost of Illness of Triple-Negative Breast Cancer in Portugal. PharmacoEconomics - Open. 9(3). 423–431.
2.
Miguel, L. Silva, et al.. (2024). Economic evaluations of medical devices in paediatrics: a systematic review and a quality appraisal of the literature. Cost Effectiveness and Resource Allocation. 22(1). 33–33.
4.
Miguel, L. Silva, et al.. (2024). Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features. Breast Cancer Research and Treatment. 211(3). 581–593.
6.
Cunha, João Paulo, et al.. (2020). PSS11 Costs and Quality of Life of RPE65-Mediated Inherited Retinal Dystrophies in Portugal. Value in Health. 23. S735–S735. 1 indexed citations
8.
9.
Miguel, L. Silva, et al.. (2018). PCN112 - BURDEN AND COSTS OF ACUTE LYMPHOBLASTIC LEUKAEMIA IN PORTUGAL. Value in Health. 21. S33–S33. 1 indexed citations
10.
Alarcão, Joana, et al.. (2017). Acute Lymphoblastic Leukaemia’s Burden Of Disease In Portugal. Value in Health. 20(9). A469–A469. 1 indexed citations
11.
Miguel, L. Silva, et al.. (2016). Cost-Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal. Value in Health. 19(7). A729–A729. 2 indexed citations
12.
Miguel, L. Silva, et al.. (2016). Cost-Effectiveness of Pembrolizumab in Patients with Advanced Melanoma Previously Treated with Ipilimumab in Portugal. Value in Health. 19(7). A730–A730. 2 indexed citations
13.
Miguel, L. Silva & Jorge Ferreira. (2016). Consequências clínicas e económicas da utilização de dabigatrano e de rivaroxabano em doentes com fibrilhação auricular não valvular. Revista Portuguesa de Cardiologia. 35(3). 141–148. 4 indexed citations
14.
Sá, Armando Brito De, Catarina Oliveira, João Filipe Raposo, et al.. (2016). A Diabetes Mellitus em Portugal: Relevância da Terapêutica Farmacológica Adequada. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Miguel, L. Silva, et al.. (2013). A cost-utility analysis of pregabalin versus venlafaxine XR in the treatment of generalized anxiety disorder in Portugal. Cost Effectiveness and Resource Allocation. 11(1). 8–8. 6 indexed citations
16.
Miguel, L. Silva, Evangelista Rocha, & Jorge Ferreira. (2013). Avaliação económica do dabigatrano na prevenção de acidentes vasculares cerebrais isquémicos em doentes com fibrilhação auricular não valvular. Revista Portuguesa de Cardiologia. 32(7-8). 557–565. 14 indexed citations
17.
Comı́n, Francisco A., et al.. (2009). Establishing priorities for the management and restoration of river basins with opencast coal mines. WIT transactions on ecology and the environment. 1. 315–326. 5 indexed citations
18.
Carrageta, Manuel, et al.. (2007). Cost-Effectiveness of Rosuvastatin in the Prevention of Ischemic Heart Disease in Portugal. Value in Health. 11(2). 154–159. 13 indexed citations
19.
Tsuchiya, Aki, L. Silva Miguel, Richard Edlin, Allan Wailoo, & Paul Dolan. (2005). Procedural Justice in Public Healthcare Resource Allocation. Applied Health Economics and Health Policy. 4(2). 119–127. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026